Alira Health’s Vice President, Regulatory, Olga Carroll, Ph.D., has developed a highlights whitepaper on the recent COVID-19 FDA guidance: [...]

Alira Health is pleased to announce its role as Advisor to Sagard NewGen for the equity investments in Laboratoires Delbert. This recent capital [...]

When our client, a leading radiopharmaceutical company, needed support to understand the commercial opportunity represented by a Phase III [...]

Alira Health is proud to announce its role as Strategic Adviser to LEO Pharma in the sale of a portfolio of four pharmaceutical products in the [...]